Gujarat Kidney And Super Speciality Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.1x)
Concerns
- Premium to sector peers (P/E 86.1x vs industry 54.7x)
- Trading near 52-week high (₹175)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Corporate Events
To consider and approve the audited financial results for the quarter and year ended March 31, 2026 and other matters
Latest News
All newsGujarat Kidney publishes annual report in newspaper
*Gujarat Kidney And Super Speciality Limited has published its annual report in a newspaper as part of regulatory compliance.* This is a routine disclosure requirement for listed companies. No financial or operational updates were provided beyond the filing. The action is procedural and does not indicate any immediate business change. 📊 *STOCKS:* $GUJARATKIT | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AnnualReport
Gujarat Kidney announces 7th AGM notice.
Gujarat Kidney And Super Speciality Limited has issued a pre-advertisement notice for its 7th Annual General Meeting (AGM). The announcement is part of routine corporate compliance and contains no material business updates. Shareholders are informed of the upcoming meeting date and agenda. No financial or operational changes were disclosed. 📊 *STOCKS:* GUJARATKB | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #AGM
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹30.58 Cr 31.5% | ₹23.25 Cr 79.8% | ₹12.93 Cr 15.3% | ₹15.26 Cr 56.0% | ₹9.78 Cr 17.0% | ₹11.79 Cr 25.3% | ₹9.41 Cr |
| Op. Profit | ₹6.3 Cr 8.7% | ₹6.9 Cr 34.8% | ₹5.12 Cr 40.6% | ₹8.62 Cr 230.3% | ₹2.61 Cr 43.3% | ₹4.6 Cr 5.3% | ₹4.86 Cr |
| OPM | 20.6% 30.6% | 29.7% 25.1% | 39.6% 29.9% | 56.5% 111.7% | 26.7% 31.6% | 39.0% 24.5% | 51.6% |
| Net Profit | ₹4.82 Cr 30.3% | ₹3.7 Cr 28.5% | ₹2.88 Cr 46.7% | ₹5.4 Cr 303.0% | ₹1.34 Cr 47.0% | ₹2.53 Cr 14.5% | ₹2.96 Cr |
| EPS (₹) | 0.64 73.0% | 0.37 21.3% | 0.47 44.7% | 0.85 269.6% | 0.23 98.5% | 15.53 15.6% | 18.39 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹82 Cr 105.0% | ₹40 Cr 700.0% | ₹5 Cr | ₹0 Cr |
| Expenses | ₹55 Cr 129.2% | ₹24 Cr 700.0% | ₹3 Cr | ₹0 Cr |
| Op. Profit | ₹27 Cr 58.8% | ₹17 Cr 750.0% | ₹2 Cr | ₹0 Cr |
| OPM | 33.0% 19.5% | 41.0% 0.0% | 41.0% | — |
| Other Income | ₹1 Cr | ₹0 Cr 100.0% | ₹1 Cr | ₹0 Cr |
| Interest | ₹2 Cr 100.0% | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹5 Cr 66.7% | ₹3 Cr | ₹0 Cr | ₹0 Cr |
| PBT | ₹21 Cr 61.5% | ₹13 Cr 550.0% | ₹2 Cr | ₹0 Cr |
| Tax % | 21.0% 19.2% | 26.0% 4.0% | 25.0% | 0.0% |
| Net Profit | ₹17 Cr 70.0% | ₹10 Cr 400.0% | ₹2 Cr | ₹0 Cr |
| EPS (₹) | 1.97 18.7% | 1.66 98.1% | 85.5 17200.0% | -0.5 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Liabilities | |||||
| Equity Capital | ₹16 Cr 40.7% | ₹11.37 Cr 3.4% | ₹11 Cr 5400.0% | ₹0.2 Cr 0.0% | ₹0.2 Cr |
| Reserves | ₹237 Cr 970.9% | ₹22.13 Cr 47.5% | ₹15 Cr 36.4% | ₹11 Cr | ₹0 Cr |
| Borrowings | ₹29 Cr 48.5% | ₹19.53 Cr 144.1% | ₹8 Cr 33.3% | ₹6 Cr | ₹0 Cr |
| Other Liabilities | ₹16 Cr 29.4% | ₹22.65 Cr 7.9% | ₹21 Cr 425.0% | ₹4 Cr 0.0% | ₹4 Cr |
| Total Liabilities | ₹298 Cr 293.8% | ₹75.68 Cr 37.6% | ₹55 Cr 161.9% | ₹21 Cr 425.0% | ₹4 Cr |
Assets | |||||
| Fixed Assets | ₹129 Cr 338.3% | ₹29.43 Cr 5.1% | ₹31 Cr 121.4% | ₹14 Cr | ₹0 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹169 Cr 265.4% | ₹46.25 Cr 92.7% | ₹24 Cr 242.9% | ₹7 Cr 75.0% | ₹4 Cr |
| Total Assets | ₹298 Cr 293.8% | ₹75.68 Cr 37.6% | ₹55 Cr 161.9% | ₹21 Cr 425.0% | ₹4 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating CF | — | ₹14 Cr 1300.0% | ₹1 Cr | ₹0 Cr |
| Investing CF | — | ₹-18 Cr | ₹0 Cr | ₹0 Cr |
| Financing CF | — | ₹6 Cr | ₹0 Cr | ₹0 Cr |
| Net Cash Flow | — | ₹2 Cr 100.0% | ₹1 Cr | ₹0 Cr |
| Free Cash Flow | — | ₹-5 Cr 350.0% | ₹2 Cr | ₹0 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Debtor Days | 172d 24.6% | 138d 57.0% | 321d | — |
| Inventory Days | 82d | — | — | — |
| Days Payable | 339d | — | — | — |
| Cash Conv. Cycle | -84d 160.9% | 138d 57.0% | 321d | — |
| Working Capital Days | 91d 479.2% | -24d 124.0% | 100d | — |
| ROCE | 14.0% 73.1% | 52.0% 173.7% | 19.0% | — |
Source: Screener.in · Lower days = better efficiency
About Gujarat Kidney And Super Speciality Limited
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
HealthcareHealthcare Services